Allarity Therapeutics Appoints Jeffrey S. Ervin as Part-Time Chief Financial Officer
Allarity Therapeutics strengthens leadership with Jeffrey S. Ervin as part-time CFO, enhancing financial strategy and corporate governance. #AllarityTherapeutics #LeadershipUpdate